Ovarian Cancer | Ursula Matulonis, MD

Data + Perspectives: Clinical Investigators Explore the Biology Underlying the Role of PARP Inhibition in the Management of Common Cancers — Faculty Presentation 1: PARP inhibitors for newly diagnosed ovarian cancer — Dr Matulonis. CME information and select publications